Terns Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
OrbiMed Advisors and its affiliates have significantly reduced their holdings in Terns Pharmaceuticals, Inc., ceasing to be beneficial owners of more than 5% of the company's common stock.